NASDAQ$OMDA
Omada Health Inc · Q4 2025 earnings
Q4 2025 earnings · · After market close
Briefing
OMDA reported Q4 2025 net sales/revenue of $76.0M, net income of $5.0M.
For Q4 2025, OMDA reported Revenue/net sales were $76.0M, net income was $5.0M. Management discusses segment performance, liquidity, and outlook in the earnings filing.
- Revenue/net sales $76.0M for Q4 2025.
- Net income $5.0M.
- MD&A covers capital allocation, costs, and sector risks.
Headline financials
Revenue & EPS history
Omada Health Inc · Revenue · Quarterly
$76M
Forward guidance
The filing discusses operating priorities, liquidity, and sector risks; numeric multi-quarter bridges vary by issuer.
Tailwinds
- MD&A highlights strategic priorities and cash runway.
- Pipeline, product, or segment commentary supports the narrative.
Headwinds
- Ongoing losses or impairment charges for pre-profit names.
- Macro, rates, or input costs may pressure margins.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 4 quarterly earnings reports · overlaid with Q4 2025
-3.9%
Avg return
Earnings day
+0.1%
Avg return
5 days after
+1.7%
Avg return
30 days after
25%
1 / 4 earnings
Positive
+3.3%
Q4 2025
Best reaction
-9.5%
Q1 2026
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -9.5% | -2.1% | +9.4% | |
| Q4 2025 | +3.3% | +1.0% | -7.5% | |
| Q3 2025 | -7.1% | -1.9% | -20.0% | |
| Q2 2025 | -2.3% | +3.2% | +24.8% |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro